These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

177 related items for PubMed ID: 10958079

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Stimulation by antipsychotic agents of mitogen-activated protein kinase (MAPK) coupled to cloned, human (h)serotonin (5-HT)(1A) receptors.
    Cussac D, Duqueyroix D, Newman-Tancredi A, Millan MJ.
    Psychopharmacology (Berl); 2002 Jul; 162(2):168-77. PubMed ID: 12110994
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Evidence that antipsychotic drugs are inverse agonists at D2 dopamine receptors.
    Hall DA, Strange PG.
    Br J Pharmacol; 1997 Jun; 121(4):731-6. PubMed ID: 9208141
    [Abstract] [Full Text] [Related]

  • 26. Agonist and antagonist properties of antipsychotics at human dopamine D4.4 receptors: G-protein activation and K+ channel modulation in transfected cells.
    Newman-Tancredi A, Heusler P, Martel JC, Ormière AM, Leduc N, Cussac D.
    Int J Neuropsychopharmacol; 2008 May; 11(3):293-307. PubMed ID: 17897483
    [Abstract] [Full Text] [Related]

  • 27. Expression and pharmacological characterization of the human D3 dopamine receptor.
    Freedman SB, Patel S, Marwood R, Emms F, Seabrook GR, Knowles MR, McAllister G.
    J Pharmacol Exp Ther; 1994 Jan; 268(1):417-26. PubMed ID: 8301582
    [Abstract] [Full Text] [Related]

  • 28. Comparison of the functional potencies of ropinirole and other dopamine receptor agonists at human D2(long), D3 and D4.4 receptors expressed in Chinese hamster ovary cells.
    Coldwell MC, Boyfield I, Brown T, Hagan JJ, Middlemiss DN.
    Br J Pharmacol; 1999 Aug; 127(7):1696-702. PubMed ID: 10455328
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. The dopamine D3 receptor partial agonist, BP 897, is an antagonist at human dopamine D3 receptors and at rat somatodendritic dopamine D3 receptors.
    Wicke K, Garcia-Ladona J.
    Eur J Pharmacol; 2001 Jul 20; 424(2):85-90. PubMed ID: 11476753
    [Abstract] [Full Text] [Related]

  • 31. Risperidone: a novel antipsychotic with balanced serotonin-dopamine antagonism, receptor occupancy profile, and pharmacologic activity.
    Leysen JE, Janssen PM, Megens AA, Schotte A.
    J Clin Psychiatry; 1994 May 20; 55 Suppl():5-12. PubMed ID: 7520908
    [Abstract] [Full Text] [Related]

  • 32. Cloning, expression, functional coupling and pharmacological characterization of the rat dopamine D4 receptor.
    Gazi L, Schoeffter P, Nunn C, Croskery K, Hoyer D, Feuerbach D.
    Naunyn Schmiedebergs Arch Pharmacol; 2000 May 20; 361(5):555-64. PubMed ID: 10832611
    [Abstract] [Full Text] [Related]

  • 33. Atypical antipsychotics: mechanism of action.
    Seeman P.
    Can J Psychiatry; 2002 Feb 20; 47(1):27-38. PubMed ID: 11873706
    [Abstract] [Full Text] [Related]

  • 34. Dopamine D2 receptor-mediated G-protein activation in rat striatum: functional autoradiography and influence of unilateral 6-hydroxydopamine lesions of the substantia nigra.
    Newman-Tancredi A, Cussac D, Brocco M, Rivet JM, Chaput C, Touzard M, Pasteau V, Millan MJ.
    Brain Res; 2001 Nov 30; 920(1-2):41-54. PubMed ID: 11716810
    [Abstract] [Full Text] [Related]

  • 35. The antipsychotics olanzapine, risperidone, clozapine, and haloperidol are D2-selective ex vivo but not in vitro.
    McCormick PN, Kapur S, Graff-Guerrero A, Raymond R, Nobrega JN, Wilson AA.
    Neuropsychopharmacology; 2010 Jul 30; 35(8):1826-35. PubMed ID: 20410873
    [Abstract] [Full Text] [Related]

  • 36. Efficacy of antipsychotic agents at human 5-HT(1A) receptors determined by [3H]WAY100,635 binding affinity ratios: relationship to efficacy for G-protein activation.
    Newman-Tancredi A, Verrièle L, Touzard M, Millan MJ.
    Eur J Pharmacol; 2001 Oct 05; 428(2):177-84. PubMed ID: 11675034
    [Abstract] [Full Text] [Related]

  • 37. Pharmacological characterization of extracellular acidification rate responses in human D2(long), D3 and D4.4 receptors expressed in Chinese hamster ovary cells.
    Coldwell MC, Boyfield I, Brown AM, Stemp G, Middlemiss DN.
    Br J Pharmacol; 1999 Jul 05; 127(5):1135-44. PubMed ID: 10455259
    [Abstract] [Full Text] [Related]

  • 38. Modulation of [(35)S]GTPgammaS binding to chinese hamster ovary cell membranes by D(2(short)) dopamine receptors.
    Terasmaa A, Finnman UB, Owman C, Ferré S, Fuxe K, Rinken A.
    Neurosci Lett; 2000 Feb 18; 280(2):135-8. PubMed ID: 10686396
    [Abstract] [Full Text] [Related]

  • 39. Aripiprazole's low intrinsic activities at human dopamine D2L and D2S receptors render it a unique antipsychotic.
    Tadori Y, Miwa T, Tottori K, Burris KD, Stark A, Mori T, Kikuchi T.
    Eur J Pharmacol; 2005 May 16; 515(1-3):10-9. PubMed ID: 15894311
    [Abstract] [Full Text] [Related]

  • 40. Differential profile of antipsychotics at serotonin 5-HT1A and dopamine D2S receptors coupled to extracellular signal-regulated kinase.
    Bruins Slot LA, De Vries L, Newman-Tancredi A, Cussac D.
    Eur J Pharmacol; 2006 Mar 18; 534(1-3):63-70. PubMed ID: 16497294
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.